Known targets — ChEMBL curated mechanism
MMP1MMP13MMP7MMP8polrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Alcohol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.33 |
| ▸ | HMGCR | P04035 | 1/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.33 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.32 |
| ▸ | CPT2 | P23786 | 1/20 | 0.31 |
| ▸ | ACLY | P53396 | 1/20 | 0.31 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | CACNA2D1 | P54289 | 2/20 | 0.31 |
| ▸ | CACNB3 | P54284 | 1/20 | 0.31 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.31 |
| ▸ | PGR | P06401 | 1/20 | 0.31 |
| ▸ | HTR2B | P41595 | 1/20 | 0.31 |
| ▸ | CACNA2D2 | Q9NY47 | 1/20 | 0.31 |
| ▸ | GABRP | O00591 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5478252 | 0.71 | ADRA1A (0.46) | KDM4EADRA1AHMGCRCHRM1TBXA2R | |
| SCHEMBL10554689 | 0.69 | HMGCR (0.34) | KDM4EADRA1AHMGCRCHRM1TBXA2R | |
| SCHEMBL750130 | 0.67 | TDP1 (0.42) | KDM4EADRA1AHMGCRCHRM1TBXA2R | |
| SCHEMBL5478250 | 0.67 | ALDH1A1 (0.32) | KDM4ECYP2D6TSHRCYP2C19HIF1A | |
| SCHEMBL7999396 | 0.66 | TDP1 (0.40) | KDM4EADRA1AHMGCRCHRM1TBXA2R | |
| SCHEMBL396503 | 0.66 | TDP1 (0.40) | KDM4EADRA1AHMGCRCHRM1TBXA2R | |
| Glycine SCHEMBL723130 | 0.64 | — | — | |
| Glycine SCHEMBL30204 | 0.64 | OR51E2 (0.71) | KDM4ECYP2D6TSHRGABRR1LMNA | |
| Glycine SCHEMBL468791 | 0.64 | OR51E2 (0.71) | KDM4ECYP2D6TSHRGABRR1LMNA | |
| SCHEMBL2778681 | 0.63 | DPP4 (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170101351-A1 | CHELATED COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME | SCOTT G. WILLIAMS, LLC | 2017-04-13 | — | — | US | disclosed |
| US-9540289-B2 | Chelated compositions and methods of making and using the same | SCOTT G. WILLIAMS, LLC (US) | 2017-01-10 | — | — | US | disclosed |
| US-20150299059-A1 | CHELATED COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME | SCOTT G. WILLIAMS, LLC | 2015-10-22 | — | — | US | disclosed |
| US-9034071-B2 | Chelated compositions and methods of making and using the same | SCOTT G. WILLIAMS, LLC (GE) | 2015-05-19 | — | — | US | disclosed |
| US-20140179945-A1 | CHELATED COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME | SCOTT G. WILLIAMS, LLC (US) | 2014-06-26 | — | — | US | disclosed |
| US-20120160001-A1 | CHELATED COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME | SCOTT G. WILLIAMS, LLC (US) | 2012-06-28 | — | — | US | disclosed |
| WO-2012088138-A1 | CHELATED COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME | SCOTT G. WILLIAMS, LLC (US) | 2012-06-28 | — | — | WO | disclosed |
| US-20100291017-A1 | Hair Treatment Compositions | CONOPCO, INC. D/B/A UNILEVER | 2010-11-18 | — | — | US | disclosed |
| EP-1959917-A1 | HAIR TREATMENT COMPOSITIONS | UNILEVER PLC (GB) | 2008-08-27 | — | — | EP | disclosed |
| WO-2007068399-A1 | HAIR TREATMENT COMPOSITIONS | UNILEVER PLC (GB) | 2007-06-21 | — | — | WO | disclosed |
| US-4215000-A | CROWN ETHER COMPLEXES; RAPID REACTION | SHELL DEVELOPMENT COMPANY (US) | 1980-07-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100291017-A1 | Hair Treatment Compositions | OAT, NACA, BCAT2 | KDM4E 2337/4885ADRA1A 4607/4885HMGCR 2392/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.